课题基金 / 基金详情

Advanced Single Cell Technology Innovation Core

Advanced Single Cell Technology Innovation Core
先进单细胞技术创新核心
批准号:
10729389
负责人:
Peter Alan Sims
金额:
$14.25万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-19 至 2028-08-31

项目摘要

项目成果

Peter Alan Sims的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 拟议中的癌症系统治疗(CastT)中心专注于了解和靶向分子 不同但共存的细胞状态和转变,建立和维持肿瘤和肿瘤细胞的生长。 系统层面的微环境。这些目标需要具有单细胞分辨率的分析方法。的 先进的单细胞技术创新核心(ASCeTIC)将提供最先进的技术, 细胞基因组分析,多重单细胞分子扰动,并在原位验证,以卡斯特研究人员。 我们将提供一套工具,包括用于联合单细胞RNA/ATAC-seq、单细胞RNA/ATAC-seq和单细胞RNA/ATAC-seq的多组学方法。 成像/RNA-seq(SCOPE-seq)和单细胞CRISPRi/RNA-seq(CROP-seq)。确认必须 用于原位验证和肿瘤微环境中细胞-细胞相互作用研究的空间分布, 我们还将提供免疫组织化学分析,RNA-FISH和循环免疫荧光(cycIF), 同时定量单个组织切片中单个细胞中的数十个蛋白质表位。
英文摘要
PROJECT SUMMARY The proposed Cancer Systems Therapeutics (CaST) Center focuses on understanding and targeting molecularly distinct yet co-existing cell states and transitions that establish and maintain tumors and tumor microenvironments at a systems level. These goals demand analytical methods with single-cell resolution. The Advanced Single Cell Technology Innovation Core (ASCeTIC) will provide state-of-the-art technology for single- cell genomic analysis, multiplexed single-cell molecular perturbation, and in situ validation to CaST investigators. We will offer a suite of tools including multi-omic methods for joint single-cell RNA/ATAC-seq, single-cell imaging/RNA-seq (SCOPE-seq), and single-cell CRISPRi/RNA-seq (CROP-seq). Recognizing the importance of spatial profiling for both in situ validation and studies of cell-cell interactions in the tumor microenvironment, we will also offer immunohistochemical analysis, RNA-FISH, and cyclic immunofluorescence (cycIF), which can simultaneously quantify tens of protein epitopes in individual cells in a single tissue section.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Bioinformatics and Single Cell Analysis Core
The Bioinformatics and Single Cell Analysis Core
Single Cell Core
Single Cell Core
海外基金